LAMPIRAN 3 Output Data Hasil Penelitian
a.Frekuensi Data Penelitian
JenisKelamin
Frequency Percent
Valid Percent Cumulative
Percent Valid
Laki-Laki 15
50,0 50,0
50,0 Perempuan
15 50,0
50,0 100,0
Total 30
100,0 100,0
Usia Kategori
Frequency Percent
Valid Percent Cumulative
Percent Valid
2 2
6,7 6,7
6,7 2-5
11 36,7
36,7 43,3
6-10 11
36,7 36,7
80,0 10
6 20,0
20,0 100,0
Total 30
100,0 100,0
Tipe
Frequency Percent
Valid Percent Cumulative
Percent Valid
ALL FAB L1 27
90,0 90,0
90,0 ALL FAB L2
3 10,0
10,0 100,0
Total 30
100,0 100,0
FaktorResiko
Frequency Percent
Valid Percent Cumulative
Percent Valid
SR 15
50,0 50,0
50,0 HR
15 50,0
50,0 100,0
Total 30
100,0 100,0
b.Uji T Test Dependent
Paired Samples Statistics
Mean N
Std. Deviation Std. Error Mean
Pair 1 UreumSebelum
20,278 27
8,5335 1,6423
UreumSesudah 27,704
27 9,5116
1,8305 Pair 2
KreatininSebelum ,2974
27 ,08667
,01668 KreatininSesudah
,4359 27
,12819 ,02467
Paired Samples Test
Paired Differences
t df
Sig. 2- tailed
Mean Std.
Deviation Std.
Error Mean
95 Confidence Interval of the
Difference Lower
Upper Pair
1 UreumSebelum -
UreumSesudah -
7,4259 7,3043
1,4057 -
10,3154 -4,5364
- 5,283
26 ,000
Pair 2
KreatininSebelum -
KreatininSesudah -
,13852 ,11723
,02256 -,18489 -,09214 -
6,140 26
,000
LAMPIRAN 4
LAMPIRAN 5
37
DAFTAR PUSTAKA
Adam, K.W., Umboh, A. Gunawan, S., 2015. Gambaran Fungsi Ginjal Pada Anak Dengan Terapi Leukemia Limfoblastik Akut di Pusat Kanker
Anak Estella RSUP Prof DR RD Kandou, Manado : FK UNSRAT. Ahmed, Y.A.A.R.., Hasan, Y., 2013. Prevention and Management of High Dose
Methotrexate Toxicity. J Cancer Science Theraphy . Volume 5, pp. 106- 112.
American Cancer Society,2014 dalam Special Section : Cancer in Children and Adolescent. Cancer Facts and Figures,2014
Bakta, I.M., 2006. Hematologi Klinik Ringkas. Jakarta : EGC. pp 120-135. Emadi, A., Jones, R.J., Brodsky, R.A., 2009. Cyclophosphamide and Cancer :
Golden Anniversary. Nature Reeviews Clinical Oncology. Volume 6, pp 638-647.
Fianza, P.I., 2009. Leukemia Limfoblastik Akut dalam Buku Ajar Ilmu Penyakit Dalam. 1st ed. Jakarta : Interna Publishing. pp 1268.
Hoffbrand, A.V., Moss, P.A.H., 2013. Kapita Selekta Hematologi. 6th ed. Jakarta : EGC. pp 210-218.
IDAI, 2006. Indonesia Protocol A. L. L. 2006 Kanwar, V. S., 2014. Pediatric Acute Lymphoblastic Leukemia Treatment
Management.[Online] Available
at: http:emedicine.medscape.comarticle990113-treatment
[Accessed 31 march 2015]. Katzung, B. G., 2010. Farmakologi Dasar dan Klinik. 10th ed. Jakarta : EGC. pp
917-920. Kosasih, A. S. et al., 2011. Immunophenotyping in the Diagnosis and
Classification of Acute Leukemia: Dharmais Cancer Hospital Experience. Indonesian Journal of Cancer, Volume 5, pp. 3-8.
Lanzkowsky, P., 2008. Manual Pediatric Hematology Oncology. London : Elsevier Inc.. pp 415-416; 426.
Mukhtar, Z., 2011. Desain Penelitian Klinis dan Statistika Kedokteran. 1st ed. Medan : USU Press, 2011.
38
Noer, M.S., 2006. Evaluasi Fungsi Ginjal Secara Laboratorik. RSU Dr. Soetomo Surabaya. FK UNAIR.
Orkin, S. H. et al., 2009. Oncology of Infancy and Childhood. 1st ed. Philadelphia: Elsevier Inc.
Perazella, d. M. A., 2012. Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents. Clinical Journal of the American Society of
Nephrology, Volume 7, pp. 1713-1721.
Permono, B. U. I., 2005. Buku Ajar Hematologi - Onkologi Anak. cetakan keempat ed. Jakarta: Badan Penerbit IDAI.
Pertiwi, N. M. I., Niruri, R. Ariawati, K., 2013. Gangguan Hematologi Akibat Kemoterapi pada Anak Dengan Leukemia Limfoblastik Akut di Rumah
Sakit Umum Pusat Sanglah, Bali: s.n.
Pinontoan, E., Mantik, M. Rampengan, N., 2013. Pengaruh Kemoterapi Terhadap Profil Hematologi pada Penderita Leukemia Limfoblastik Akut,
Manado: FK UNSRAT.
Pui, C., 2006. Treatment of Acute Limphoblastic Leukemia. The New England Journal, pp. 111-118.
Robinson, L.L., 2011. Late Effects of Acute Lymphoblastic Leukemia Therapy in Patients Diagnosed at 0-20 Years of Age. American Society of
Hematology. pp 238-242. Roganovic, J., 2013. Acute Lymphoblastic Leukemia in Children, Leukemia.
[Online] Available
at: http:www.intechopen.combooksleukemiaacute
lymphoblastic-leukemia-in-children [Accessed 25 April 2015].
Sastroasmoro, S., 2011. Dasar-Dasar Metodologi Penelitian Klinis. 4th ed. Jakarta: Sagung Seto.
Sumantri, A., 2011. Metodologi Penelitian Kesehatan. 1st ed. Jakarta: Kencana Prenada Media Group.
Tamsil, F., Mantik, M. Umboh, A., 2014. Analisis Kadar Kreatinin pada Anak dengan Leukemia Limfoblastik Akut di Pusat Kanker Anak Estella Blu
RSUP Prof Dr Rd Kandou, Manado : FK UNSRAT.
Vagace, J.M., Gervasini, G., 2011. Chemotherapy Toxicity in Patients with Acute Leukemia. University of Extremadura, Bandajoz, Spain.
39
Widiaskara, I.M., Permono, B., Ugrasena I.D.G., Ratwita, M., 2010. Luaran Pengobatan Fase Induksi Pasien Leukemia Limfoblastik Akut pada Anak
di Rumah Sakit Umum Dr. Sutomo Surabaya. Sari Pediatri. Vol. 12. pp 128-134.
Yetgin, Sevgi., Olgar, Seref., 2004. Evaluation of Kidney Damage in Patients With Acute Lymphoblastic Leukemia in Long-Term Follow-Up: Value of
Renal Scan. American Journal of Hematology 77:132 –139.
24
BAB 3 KERANGKA TEORI, KERANGKA KONSEP, DEFINISI
OPERASIONAL DAN HIPOTESIS
3.1 Kerangka Teori
Kategori